Convalescent Plasma News and Research

RSS
NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

Serological antibody response to SARS-CoV-2 infection at a population level

Serological antibody response to SARS-CoV-2 infection at a population level

Efficacy of COVID-19 convalescent plasma therapy in patients with hematological malignancies and COVID-19

Efficacy of COVID-19 convalescent plasma therapy in patients with hematological malignancies and COVID-19

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Researchers suggest hybrid convalescent plasma therapy neutralizes the omicron variant

Researchers suggest hybrid convalescent plasma therapy neutralizes the omicron variant

Early administration of SARS-CoV-2 convalescent plasma reduces outpatient hospitalizations

Early administration of SARS-CoV-2 convalescent plasma reduces outpatient hospitalizations

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Convalescent plasma not recommended for patients with covid-19, WHO experts say

Convalescent plasma not recommended for patients with covid-19, WHO experts say

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

Study explores adverse effects of SARS-CoV-2-induced antibody responses

Study explores adverse effects of SARS-CoV-2-induced antibody responses

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program